1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Digital Europe Programme AI-Powered Medical Image Screening for Cancer and Cardiovascular Disease Detection is sponsored by European Commission (Digital Europe Programme). This call supports the development and piloting of scalable cloud-based AI and Generative AI systems for medical image screening in real-world healthcare settings, specifically targeting cancer and cardiovascular disease detection, prevention, and early diagnosis.
Get alerted about grants like this
Save a search for “European Commission (Digital Europe Programme)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Info Day on digital health topics under the DIGITAL Europe Programme - Apply AI: Piloting AI-based image screening in medical centres | Shaping Europe’s digital future Info Day on digital health topics under the DIGITAL Europe Programme - Apply AI: Piloting AI-based image screening in medical centres Publication 29 April 2026 Discover the policy and funding requirements, get your questions answered, and pitch your organisation’s idea for a chance to pilot AI-powered screening services across Europe.
This online session will provide information for applicants interested in the call for proposals DIGITAL-2026-AI-PILOTING-10-SCREENING - Apply AI: Piloting AI-based image screening in medical centres. Join the live stream .
You can also submit your questions about the call ahead of the session via Slido , using the passcode: AI2105 This topic aims to accelerate the adoption and deployment of cloud-based AI systems running European AI algorithms for medical image screening, with a focus on the early detection and diagnosis of cancer and cardiovascular diseases. Two projects will be funded under this call for proposals.
These projects will pilot the deployment of cloud-based AI systems to: Improve efficiency in detection and diagnostic workflows in the areas of cancer and/or cardiovascular diseases Support the prioritisation of critical cases Reduce pressure on radiology services Contribute to more equitable access to screening services, including in underserved regions This topic contributes to the Apply AI strategy .
In particular, the flagship initiative European AI-powered advanced screening centres , which will speed up the introduction of innovative AI solutions for disease prevention, early detection and diagnosis, and support Europe’s fight against cancer and cardiovascular diseases.
€9 M (€4,5 M per project) Number of projects expected Indicative duration of the action 1 October 2026, 17:00 CET (Brussels) Anca SCORTARIU (CNECT A6) Anca SCORTARIU (CNECT A6) Call topic presentation: Apply AI: Piloting AI-based image screening in medical centres and Questions & Answers (Q&A) Matthieu RUTHVEN & Vanessa MENDES (CNECT A6) Financial requirements and guidance, and Q&A Restricted calls guidance and Q&A Mateja POGACIC (CNECT R5) Stakeholder presentations Organisations potentially interested in the call can register to present their organisation/idea in a dedicated pitching session (maximum 3 minutes and up to 3 slides per participant).
If you are interested, please register using the form . Please note that there are a limited number of pitching slots and these will be allocated on a first-come, first-served basis. For information about how the European Commission processes your personal data, please read the Privacy Statement below.
If you have any questions regarding the call, please contact your National Contact Point for Digital Europe or ask a question through the Q&A functionality in the Funding and Tender Portal .
For additional information on the Digital Europe Programme, check: Digital Europe Programme (DIGITAL) Amendment of the Digital Europe Work Programme 2025-2027 National Contact Points for Digital Europe Frequently Asked Questions (FAQ) Watch the video below to check on you can obtain a Participant Identification Code. Privacy statement for Info Day Call 10 - Apply AI
According to the current listing, eligibility includes: Open to businesses, public administrations, academia, healthcare providers, and other entities from EU Member States and associated countries. Confirm the full requirements in the official notice before applying.
The current listing shows up to €4,500,000 per project (total budget €9,000,000). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Digital Europe Programme AI-Powered Medical Image Screening for Cancer and Cardiovascular Disease Detection are due September 30, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Digital Europe Programme AI-Powered Medical Image Screening for Cancer and Cardiovascular Disease Detection is funded by European Commission (Digital Europe Programme). Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Support to the Implementation of Multi-Country Projects (EDIC Support Hub) is a grant from the European Commission under the Digital Europe Programme that funds the establishment of a hub providing technical, legal, and operational assistance to European Digital Infrastructure Consortia. With an award ceiling of EUR 1,000,000 and a deadline of September 30, 2026, this call supports organizations coordinating multi-country digital projects across EU member states and associated countries. Eligible applicants include government bodies and private sector organizations from EU member states and Digital Europe Programme participating nations.
Research Support Framework for Situational Awareness on Information Integrity is a grant from the European Commission's Digital Europe Programme that funds the establishment of the first Common Research Framework on Information Integrity, implementing a key deliverable of the European Democracy Shield Communication of November 2025. The program aims to bridge gaps and silos in existing research efforts by fostering collaboration across communities, disciplines, and borders; expanding research capabilities through targeted distribution of funds; securing or establishing necessary technological infrastructure for advanced information integrity research; and facilitating knowledge-sharing on regulatory tools available to researchers. Eligible applicants include businesses, organizations, and public administrations from Europe and associated countries. The application deadline is September 30, 2026. This call falls under the DIGITAL-2026-BESTUSE-RSF-10-AWARENESS solicitation.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
DARPA-PS-26-04, published February 25, 2026 by the Tactical Technology Office, restructures the contract around three phases — Phase 0 Backbone (6 months), Phase 1 Base (12 months), Phase 2 Option (18 months) — and culminates in an instrumented flight-test campaign. The solicitation is not really about T&E. It is about the digital-twin and uncertainty-quantification middleware DoD needs for any AI-enabled combat system.
Read articleThe EU's last major Horizon Europe work programme puts €14B on the table through 2027. A strategic breakdown of budgets, deadlines, eligibility, and how US-based teams can compete.
Read articleThe EU committed €900 million to lure researchers with relocation grants worth up to €2 million each. France placed 41 of 46 recruits from the US. Here is what the global talent war means for American research institutions and grant seekers.
Read article